Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02230267 · ClinicalTrials.gov registry record · Phase 2

High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease

A Phase 2 study of Parkinson's Disease, sponsored by University of Nevada, Las Vegas.

Completed
Registry status
Phase 2
Development phase
27
Enrollment target
1
Study location

NCT02230267: Completed Phase 2 study of Parkinson's Disease, sponsored by University of Nevada, Las Vegas.

NCT02230267 is a Phase 2 study of Parkinson's Disease that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 27 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02230267, a Phase 2 study of Parkinson's Disease, has completed, sponsored by University of Nevada, Las Vegas.

COMPLETED
Registry status
Phase 2
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

Several animal and human epidemiologic studies have provided evidence that exercise may be neuroprotective in Parkinson's disease (PD). Exercise may forestall diagnosis and, in the case of those who have already been diagnosed with PD, it may slow the observed neurodegeneration. Unfortunately, because this line of research is in early stages, there is little evidence to indicate what biological mechanisms underlie the neuroprotection that is conferred with exercise. Toward this end, it is possible that an interaction between endogenous antioxidant enzymes, inflammatory processes, and reactive oxygen species may be associated with exercise improvements in PD. One of the most common reasons for premature death in PD is falls. Several meta-analyses have concluded that exercise training programs focused on balance and/or strength training are effective at improving aspects of balance. Taken together, the current body of evidence suggests that exercise may be neuroprotective and balance/strength training may decrease the likelihood of a fall. The combination of these efficacious treatment modalities (exercise and balance/strength training) in a comprehensive treatment approach to improve PD symptoms and balance has been previously reported at relatively mild or moderate exercise intensities. Because recent research has suggested that patients with PD may benefit more from more physically intense programs, we are proposing a more aggressive approach with regard to exercise intensity and frequency in the present trial. The primary purpose of this study is to determine the feasibility and safety of a high intensity exercise approach to PD. A secondary purpose is to determine the trajectory of change in outcomes over the duration of the trial from a high intensity fall prevention program. It is hoped that a signal of efficacy will allow this trial to progress to a comparative effectiveness trial. An important innovative design element is collecting biological assays to bett

Primary Outcome

The number of participants that attend and participate in the treatment at least 3 times per week for 8 weeks.

Conditions Studied

Interventions

  • OTHER High intensity exercise and balance training
  • OTHER Usual care arm exercise

Study Locations (1)

Nevada

  • University of Nevada, Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2014-08
Est. Completion 2015-12
Phase Phase 2
University of Nevada, Las Vegas

52 total trials

What the finished NCT02230267 record still lists

NCT02230267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which High intensity exercise and balance training is the first listed.

NCT02230267 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT02230267 about?

NCT02230267 is a clinical study titled "High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease". Several animal and human epidemiologic studies have provided evidence that exercise may be neuroprotective in Parkinson's disease (PD). Exercise may forestall diagnosis and, in the case of those who have already been diagnosed with PD, it may slow the observed neurodegeneration. Unfortunately, becau...

What is the current status of trial NCT02230267?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2014-08. Estimated completion is 2015-12.

What conditions does trial NCT02230267 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02230267?

The interventions under investigation include: High intensity exercise and balance training (OTHER), Usual care arm exercise (OTHER).

Who is sponsoring clinical trial NCT02230267?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02230267 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02230267's enrollment target sits among peer trials

27 114th of 158 higher than 42 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02230267, the US trial registry maintained by the National Library of Medicine. NCT02230267 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.